F. Ince

发表

QSAR and the rational design of long-acting dual D2-receptor/beta 2-adrenoceptor agonists.

R. Austin, P. Barton, A. Davis, 2003, Journal of medicinal chemistry.

The medicinal chemistry of the P2 receptor family.

M. Mortimore, N. Kindon, A. Ingall, 2001, Progress in medicinal chemistry.

Discovery and synthesis of methyl 2,5-dimethyl-4-[2- (phenylmethyl)benzoyl]-1H-pyrrole-3-carboxylate (FPL 64176) and analogues: the first examples of a new class of calcium channel activator.

S. Teague, F. Ince, A. Baxter, 1993, Journal of medicinal chemistry.

Novel cobalt complex inhibitors of mitochondrial calcium uptake.

J. Unitt, A. Wallace, A. Ingall, 1999, Bioorganic & medicinal chemistry.

Dual D2 Dopamine Receptor and β2-Adrenoceptor Agonists for the Modulation of Sensory Nerves in COPD

P. Newbold, A. Young, I. Dougall, 2001 .

From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.

P. Leeson, B. Springthorpe, P. Barton, 2007, Bioorganic & medicinal chemistry letters.

Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues.

R C Brown, A M Davis, W. T. Simpson, 1998, Journal of medicinal chemistry.

Dual dopamine D2 receptor and beta2-adrenoceptor agonists for the treatment of chronic obstructive pulmonary disease: the pre-clinical rationale.

D. Jackson, A. Young, I. Dougall, 2003, Respiratory medicine.

A Mild and Convenient High-Yield Alternative to the Protic Acid Catalysed Pictet-Spengler Synthesis of Tetrahydroisoquinolines

H. Heaney, M. Earle, S. Eyley, 1991 .

Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitors.

Martin Braddock, Mark Furber, Keith Bowers, 2007, Journal of medicinal chemistry.